Genentech, a member of the Roche Group, has broken ground on its newest US manufacturing site in Holly Springs, North Carolina.
This significant development marks the establishment of Genentech’s first manufacturing facility on the East Coast.
The 65,000 sq m facility is strategically designed to support production of the company’s future portfolio of metabolic medicines, including next-generation treatments for obesity. [Read more…] about Genentech breaks ground on $700 million manufacturing facility in the US